: Medicare drug price negotiations move forward with all drugmakers participating, White House says
Read Time:3 Second
Novo Nordisk is latest drugmaker to challenge negotiation program in court.
Fines follow probe of Harvest’s Collateral Yield Enhancement Strategy (CYES).
New-home sales fell in August, but still beat estimates.
Nearly 80% of workers say they don’t know much about their finances.
Nvidia’s stock is gaining as a new report projecting big growth in the AI market offers some relief to investors...
Stocks can still ‘do well,’ but the compensation for taking equity risk is near the lowest in 20 years, BlackRock...
FanDuel boosted its outlook for the size of the total addressable market in North America.